Select Medical (NYSE:SEM) Downgraded by StockNews.com to Hold

StockNews.com cut shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a report published on Monday.

SEM has been the subject of several other reports. Royal Bank of Canada lifted their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th.

Select Medical Stock Performance

NYSE SEM opened at $18.80 on Monday. The stock has a market capitalization of $2.43 billion, a PE ratio of 8.79, a P/E/G ratio of 0.39 and a beta of 1.43. Select Medical has a 1 year low of $18.02 and a 1 year high of $40.98. The company’s 50 day simple moving average is $28.01 and its two-hundred day simple moving average is $32.62. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13.

Select Medical (NYSE:SEM) last released its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the company posted $0.46 EPS. Select Medical’s quarterly revenue was up 5.7% compared to the same quarter last year. Analysts predict that Select Medical will post 1.97 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. The ex-dividend date of this dividend was Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 2.66%. Select Medical’s dividend payout ratio (DPR) is 23.36%.

Insider Activity at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of Select Medical stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at $463,980. This trade represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by insiders.

Institutional Trading of Select Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP raised its position in shares of Select Medical by 2.2% in the second quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after acquiring an additional 95,578 shares during the period. Geode Capital Management LLC grew its holdings in Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after buying an additional 46,880 shares in the last quarter. Principal Financial Group Inc. raised its stake in Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after purchasing an additional 147,032 shares during the period. Point72 Asset Management L.P. raised its position in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after buying an additional 1,216,263 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Select Medical by 1.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after purchasing an additional 24,439 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.